Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 20
2003 24
2004 20
2005 18
2006 11
2007 9
2008 6
2009 11
2010 7
2011 19
2012 15
2013 16
2014 16
2015 11
2016 18
2017 16
2018 15
2019 16
2020 46
2021 24
2022 30
2023 25
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

369 results

Results by year

Filters applied: . Clear all
Page 1
The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis.
Bousquet J, Toumi M, Sousa-Pinto B, Anto JM, Bedbrook A, Czarlewski W, Valiulis A, Ansotegui IJ, Bosnic-Anticevich S, Brussino L, Canonica GW, Cecchi L, Cherrez-Ojeda I, Chivato T, Costa EM, Cruz AA, Del Giacco S, Fonseca JA, Gemicioglu B, Haahtela T, Ivancevich JC, Jutel M, Kaidashev I, Klimek L, Kvedariene V, Kuna P, Larenas-Linnemann DE, Lipworth B, Morais-Almeida M, Mullol J, Papadopoulos NG, Patella V, Pham-Thi N, Regateiro FS, Rouadi PW, Samolinski B, Sheikh A, Taborda-Barata L, Ventura MT, Yorgancioglu A, Zidarn M, Zuberbier T. Bousquet J, et al. Among authors: lipworth b. J Allergy Clin Immunol Pract. 2022 Nov;10(11):2878-2888. doi: 10.1016/j.jaip.2022.07.020. Epub 2022 Aug 4. J Allergy Clin Immunol Pract. 2022. PMID: 35934308
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS).
Cotton S, Devereux G, Abbas H, Briggs A, Campbell K, Chaudhuri R, Choudhury G, Dawson D, De Soyza A, Fielding S, Gompertz S, Haughney J, Lang CC, Lee AJ, MacLennan G, MacNee W, McCormack K, McMeekin N, Mills NL, Morice A, Norrie J, Petrie MC, Price D, Short P, Vestbo J, Walker P, Wedzicha J, Wilson A, Lipworth BJ. Cotton S, et al. Among authors: lipworth bj. Trials. 2022 Apr 14;23(1):307. doi: 10.1186/s13063-022-06226-8. Trials. 2022. PMID: 35422024 Free PMC article. Clinical Trial.
Non-canonical β2-receptor signaling.
Lipworth B, Chan R, RuiWen Kuo C. Lipworth B, et al. J Allergy Clin Immunol. 2019 Dec;144(6):1735. doi: 10.1016/j.jaci.2019.08.017. Epub 2019 Sep 26. J Allergy Clin Immunol. 2019. PMID: 31564472 No abstract available.
H1-antihistamines.
Lee DK, Currie GP, Lipworth BJ. Lee DK, et al. Among authors: lipworth bj. N Engl J Med. 2005 Mar 17;352(11):1155-7; author reply 1155-7. doi: 10.1056/NEJM200503173521124. N Engl J Med. 2005. PMID: 15784676 No abstract available.
Emerging pharmacotherapy for COVID-19.
Lipworth B, Kuo CR, Chan R. Lipworth B, et al. J R Coll Physicians Edinb. 2020 Jun;50(2):133-137. doi: 10.4997/JRCPE.2020.210. J R Coll Physicians Edinb. 2020. PMID: 32568282 Review.
Levalbuterol kinetics.
Lipworth BJ, Clearie K. Lipworth BJ, et al. J Allergy Clin Immunol. 2009 Jan;123(1):275. doi: 10.1016/j.jaci.2008.10.055. J Allergy Clin Immunol. 2009. PMID: 19130946 No abstract available.
Current appraisal of single inhaler triple therapy in COPD.
Lipworth B, Kuo CR, Jabbal S. Lipworth B, et al. Int J Chron Obstruct Pulmon Dis. 2018 Sep 28;13:3003-3009. doi: 10.2147/COPD.S177333. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30319248 Free PMC article. Review.
369 results